Company Analysis

Lisata Therapeutics, Inc. (LSTA)

Nasdaq: LSTA · Pharmaceutical Preparations · Basking Ridge, NJ · filing with the SEC since 1995
Grade4.2
◀ Past 3.8● Present 4.5▶ Future 4.2
2 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 12, 2026Feb 27, 2025Feb 29, 2024Mar 30, 2023Mar 22, 2022Feb 25, 2021Mar 5, 2020Mar 14, 2019Mar 22, 2018Mar 17, 2017
Revenue170,0001,000,00000·····35,283,868
Cost of revenue·········31,136,129
Research and development7,949,00011,334,00012,734,00013,067,00017,576,0009,253,00010,797,0007,594,00015,843,000r16,699,213r
Selling, general and administrative··12,974,00014,141,00011,474,000r9,892,0009,295,0009,393,00011,750,000r12,802,735r
General and administrative10,430,00012,075,00012,974,000·······
Total operating expenses18,379,00023,409,00025,708,00057,601,00029,050,00019,145,00020,092,00016,987,00027,593,000r29,501,948r
Operating income-18,209,000-22,409,000-25,708,000-57,601,000-29,050,000-19,145,000-20,092,000-16,987,000-27,593,000r-29,501,948r
Interest expense······05,000378,000r1,779,657r
Interest and investment income806,0001,883,0002,724,0001,052,000151,000132,000····
Share of profit of equity-method investments0-130,0000·······
Other income (expense), net-145,000-257,000-186,000-155,000-75,0000r740,000824,000273,000r23,854r
Total non-operating income (expense)661,0001,626,0002,538,000897,00076,000132,000740,000819,000-105,000r-1,755,803r
Income before income taxes-17,548,000-20,783,000-23,170,000-56,704,000-28,974,000-19,013,000-19,352,000-16,168,000-27,698,000r-31,257,751r
Income tax expense-962,000-798,000-2,330,000-2,479,000-1,508,000-10,872,00000-11,527,000r0r
Income from continuing operations·······-16,167,000-15,989,000r-31,015,949
Income from discontinued operations·······038,399,000r-2,051,782
Net income including non-controlling interests-16,586,000-19,985,000-20,840,000-54,225,000-27,466,000-8,141,000-19,352,000-16,168,00022,228,000r-33,309,533
Net income-16,586,000-19,985,000-20,840,000-54,225,000-27,466,000-8,150,000-19,361,000-16,167,00022,979,000r-32,656,319
Net income to common shareholders·········-32,656,319
Earnings per share, basic-1.91-2.40-2.58-10.47-7.45r-7.95b·-25.05b38.40b-74.85b
Earnings per share, diluted-1.91-2.40-2.58-10.47-7.45r-7.95b··38.40b-74.85b
Earnings per share, basic and diluted·····-7.95b-28.20b-25.05b·-74.85b
Weighted average shares, basic8,687,0008,329,0008,073,0005,180,0003,688,000r1,029,333b·645,933b597,933rb436,550b
Weighted average shares, diluted8,687,0008,329,0008,073,0005,180,0003,688,000r1,029,333b·645,933b597,933rb436,550b
Weighted average shares, basic and diluted·····1,029,333b688,333b645,933b··
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton LSTA · research, not advice